Physician

Aamir Makda, M.D.

According to 2025 Medicare claims, Aamir Makda, M.D. (NPI: 1750959367) practices internal medicine, with the plurality of this provider's patient population coming from Sussex, DE. This provider's primary affiliated billing organization is APOGEE MEDICAL GROUP, DELAWARE, INC (NPI: 1326485285; TIN: 462187372) and primary practice location at 19963-4364.

Makda's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 134 traditional Medicare patients, billed 179 HCPCS/CPT codes, and received $17,199 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 162 prescription claims across 52 beneficiaries totaling $12,404 in drug costs, led by Metoprolol Succinate (Metoprolol Succinate). Open Payments data shows 4 records totaling $173. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, this provider has fewer than 5 years of reported Part D prescription costs data, so a reliable trend cannot be assigned. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$8.6K$17K2024 Medicare payment: $17,199 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024134179$17,199

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$11K$22K2021 Drug cost: $2,128 (USD; Tot_Drug_Cst)2022 Drug cost: $14,038 (USD; Tot_Drug_Cst)2023 Drug cost: $21,866 (USD; Tot_Drug_Cst)2024 Drug cost: $12,404 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
20212562$2,128
202258193$14,038
202344226$21,866
202452162$12,404

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes4243$134
99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes5861$100
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes1114$92
99239Hospital discharge day management, more than 30 minutes1111$89
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes2540$61

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Metoprolol SuccinateMetoprolol Succinate161,214$341
Atorvastatin CalciumAtorvastatin Calcium12840$39

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.4$173GENZYME CORPORATION
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Aamir Makda, M.D.?

Tedicare shows public-source Medicare data for Aamir Makda, M.D. (NPI 1750959367), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aamir Makda, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Aamir Makda, M.D.?

Aamir Makda, M.D. is linked to APOGEE MEDICAL GROUP, DELAWARE, INC (billing NPI 1326485285) in the available physician profile data.

Does Aamir Makda, M.D. have Open Payments data?

Aamir Makda, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.